Most medical treatments are designed for the "average patient" as "one-size-fits-all-approach," that is successful for some patients but not for others. Precision medicine, sometimes known as "personalized medicine" is an innovative approach to disease prevention and treatment that takes into account differences in peopl’s genes, environments and lifestyles.

Advances in precision medicine have already led to powerful new discoveries and several new treatments that are tailored to specific characteristics of individuals, such as a person’s genetic makeup, or the genetic profile of an individual’s tumor. Patients with a variety of cancers routinely undergo molecular testing as part of patient care, enabling physicians to select treatments that improve chances of survival and reduce exposure to adverse effects.

To advance these developments, CRU’s Personalized Medicine at Bedside Program seeks to identify genetically-based drivers of disease in order to develop new, more effective treatments and to bring such possibilities from the lab to the bedside.